ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.15
-0.15 (-2.38%)
Nov 6, 2025, 10:43 AM EST - Market open
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $55.63 million as of November 6, 2025. Its market cap has increased by 100.06% in one year.
Market Cap
55.63M
Enterprise Value
65.26M
1-Year Change
100.06%
Ranking
Category
Stock Price
$6.15
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $55.63M, an increase of 2,692.77%. That is a compound annual growth rate of 10.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 56.99M | 24.17% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | 42.92M | 15.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 791.72B |
| Johnson & Johnson | 453.00B |
| AbbVie | 377.71B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 213.81B |